Nextech Invest Ltd. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nextech Invest Ltd. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2022$8,246,269
-33.5%
188,2280.0%3.28%
-18.1%
Q3 2022$12,402,000
+30.5%
188,2280.0%4.01%
+24.9%
Q2 2022$9,507,000
-20.9%
188,2280.0%3.21%
-6.6%
Q1 2022$12,024,000188,2283.43%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders